Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Efamol Nutraceuticals

This article was originally published in The Tan Sheet

Executive Summary

National Advertising Division of the Council of Better Business Bureaus terminates its inquiry into advertising for Efamol's Efalex dietary supplement because the claims already are undergoing regulatory review. NAD had requested Efamol provide substantiation for claims made in a print ad that use of Efalex is an efficient way to manage fatty acid deficiency in children and implied claims the product can be used to treat Attention Deficit-Hyperactivity Disorder. Distributed by Nature's Way, Efalex for essential fatty acid-"deficient" children began shipping in July 1997 (1"The Tan Sheet" July 28, 1997, p. 17). Royal Numico acquired Efamol in 1998 (2"The Tan Sheet" July 12, p. 3)

You may also be interested in...



GNC To Gain Broad R&D Pipeline From New Owner Royal Numico

The acquisition of General Nutrition Companies by the Dutch conglomerate Royal Numico will give the Pittsburgh-based supplement retailer an extensive R&D foundation on which to develop original nutritional products. The agreement was announced July 5.

Nature's Way/Efamol introduce Efalex Focus for EFA-"deficient" children.

NATURE's WAY/EFAMOL EFALEX FOCUS FOR EFA-"DEFICIENT" CHILDREN provides "essential fatty acids found to be deficient in many children struggling with coordination, visual difficulties, learning ability and behaving at school," a product brochure states. "Best of all," Efalex Focus is a "safe and natural alternative. And that's especially important to parents concerned about what they give their children," the companies claim. The brochure portrays a child hunched over a book, with the tagline "Help him to see reason. Naturally."

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS090329

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel